Cargando…
Pterisolic Acid B is a Nrf2 Activator by Targeting C171 within Keap1-BTB Domain
The use of chemoprotective agents to minimize the side effects of the chemotherapy, primarily via activation of the Nrf2 pathway, is an emerging research field, which has attracted broad attention from both academia and pharmaceutical industry. Through high-throughput chemical screens we have disclo...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725373/ https://www.ncbi.nlm.nih.gov/pubmed/26757824 http://dx.doi.org/10.1038/srep19231 |